Allison Carey, MD, PhD, pictured in her lab at the University of Utah, developed a molecular barcoding approach to identify genetic variants that make some strains of Mycobacterium avium more resistant to antibiotics.
Allison Carey, MD, PhD, ARUP medical director of Hematopathology, was one of six U faculty members recognized for research excellence and invited to share their stories at the Vitae 2022 symposium.
ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in January.
ARUP Consult, a free source of expert guidance in laboratory testing, has updated resources on testing for bariatric surgery, respiratory viruses, and alpha-1-antitrypsin deficiency.
Erik Forsman draws on his seven years of experience as a healthcare data consultant to share the foundations of a holistic, in-house data analytic system in a new Journal of Applied Laboratory Medicine (JALM) article.
Erik Forsman, a senior data consultant for ARUP Healthcare Advisory Services, has published a new article in The Journal of Applied Laboratory Medicine to share the benefits of in-house data systems.
Nathan Boggs, MD, PhD, an assistant professor of medicine at the Uniformed Services University who is engaged in systemic mastocytosis (SM) translational research, helped Mark Withers, MD, obtain a definitive diagnosis of SM after 20-plus years. Tracy George, MD, ARUP Laboratories president and chief scientific officer, has led the effort to develop highly sensitive tests at ARUP that aid in the diagnosis of SM and has played a key role in clinical trials for emerging treatments.
For 20-plus years, Mark Withers had inexplicable episodes of a severe anaphylaxis-like phenomenon. ARUP’s unique expertise and highly sensitive tests help patients like him find the right diagnosis.
Cases of respiratory syncytial virus (RSV), influenza, and COVID-19 in children, older adults, and other vulnerable populations are on the rise and warrant laboratory testing to inform treatment.
As respiratory viruses cocirculate this season, laboratory testing is increasingly essential to inform treatment of children, older adults, and other vulnerable populations.
Tony Smith, BS(HCM), MLT(ASCP), senior healthcare consultant at ARUP Laboratories, is the author of a newly published article in Clinical Laboratory News that offers guidelines for creating strong governance structures to ensure sustainability of laboratory stewardship programs.
Successful stewardship relies on good governance, and in a new article, ARUP Senior Healthcare Consultant Tony Smith details how labs can leverage their expertise to better meet stewardship goals.
ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in December.
ARUP Consult, a free source of expert guidance in laboratory testing, has released new and updated educational resources for multiple sclerosis, minimal residual disease, and mumps virus.
A new ARUP Consult tool helps clarify the testing requirements for medication management when clinicians are treating patients with multiple sclerosis.
Jennifer (Jenna) Rychert, PhD, ARUP medical director of Operational Informatics and Microbial Immunology, and Jonathan Genzen, MD, PhD, ARUP chief medical officer, coauthored the report of the new study, “Laboratory-Developed Test Orders in an Academic Health System.”
Laboratory-developed tests made up only about 4% of an academic health system’s total test orders in 2021, yet they played an important role in patient care, a new study shows.
ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in November.
ARUP Consult, a free source of expert guidance in laboratory testing, has updated educational resources for venous thromboembolism, cytomegalovirus, and hemoglobinopathies.
The condition of venous thromboembolism, illustrated here, can be treated using direct oral anticoagulants (DOACs) such as direct factor Xa inhibitors. ARUP’s new chromogenic assays can be used to help assess treatment efficacy.
Routine monitoring of patients taking direct factor Xa inhibitors is not required, but the efficacy and safety of this treatment can be measured with ARUP’s newest test offerings.
ARUP Chief Medical Officer Jonathan Genzen, MD, PhD (left), and Lauren Pearson, DO, MPH, chief medical officer of ARUP at University of Utah Health, are coauthors of a newly published JAMA Research Letter that summarizes results of a survey of clinical labs to evaluate adoption of a new equation to assess kidney function based on creatinine in patient serum. The new equation eliminates adjustment factors for race.
ARUP CMOs are coauthors of a newly published JAMA Research Letter that summarizes how clinical labs are leading the way in eliminating inequality in healthcare.